Viridian Therapeutics Inc

Viridian Therapeutics Inc(VRDN)價格預測

$22.780

-0.248 (-1.09%)收盤時

價格預測

1-Day Price Prediction
+0.13%
1-Week Prediction
-0.52%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

VRDN 相似圖表分析預測

Alphio's VRDN stock price prediction model matches the current Viridian Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $22.99 (+0.13%). The 1-week path is $22.84 (-0.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Viridian Therapeutics Inc 股票嗎?

Viridian Therapeutics (VRDN) appears to be a good buy right now, trading at $23.08 with a forward P/E of 1.0072, indicating potential undervaluation. The recent FDA approval for Lumvoa therapy for thyroid eye disease is a significant positive catalyst, expected to drive revenue growth. However, the current RSI of 38.888 suggests the stock is near oversold territory, which could lead to a rebound. The main risk is the negative net income of -127,119,000 USD reported in Q2 2026, which reflects ongoing financial challenges that investors should monitor closely.

VRDN 股價於 Wednesday 收在 $22.78,此前下跌 -1.09%

Viridian Therapeutics Inc (VRDN) last closed at $22.96, gaining +0.79%. These facts feed the 1-day and 1-week VRDN price prediction above.

預測驅動因素

Viridian Therapeutics Inc(VRDN)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 VRDN 最接近的股票,依相似度排序。

VRDN 季節性分析

Historically the probability of a positive September return for VRDN is 22.73%. October offers the highest probability of a positive month at 93.48%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

VRDN 十年價格預測

月份最低價平均價最高價潛在報酬率
Sep 2026$8.18$11.41$13.25-50.29%
Oct 2026$11.92$13.50$13.82-41.20%
Nov 2026$12.29$12.44$16.30-45.81%
Dec 2026$11.34$13.54$17.31-41.02%

2026 年,Viridian Therapeutics Inc(VRDN)預計區間為 $8.18 至 $17.31。

Viridian Therapeutics Inc 2026 年月度預測

VRDN 2026 年 Sep 預測
潛在報酬率:-50.29%

2026 年 Sep,Viridian Therapeutics Inc 預計均價 $11.41,最低 $8.18,最高 $13.25。

VRDN 2026 年 Oct 預測
潛在報酬率:-41.20%

2026 年 Oct,Viridian Therapeutics Inc 預計均價 $13.50,最低 $11.92,最高 $13.82。

VRDN 2026 年 Nov 預測
潛在報酬率:-45.81%

2026 年 Nov,Viridian Therapeutics Inc 預計均價 $12.44,最低 $12.29,最高 $16.30。

VRDN 2026 年 Dec 預測
潛在報酬率:-41.02%

2026 年 Dec,Viridian Therapeutics Inc 預計均價 $13.54,最低 $11.34,最高 $17.31。

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始